MyAverix Finance
SHG · Healthcare
Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168)
Drug Manufacturers - Specialty & Generic
Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-28, reported market cap is $2.59B, P/E ratio is 18.00, net margin is -13.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 603168
Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) — FAQ
What is Zhejiang Shapuaisi Pharmaceutical Co Ltd's market cap?
Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) has a reported market cap of $2.59B (data as of 2026-03-28).
What is 603168's P/E ratio?
The price-to-earnings (P/E) ratio for Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) is 18.00 (data as of 2026-03-28).
Does Zhejiang Shapuaisi Pharmaceutical Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168). Check the MyAverix Finance app for the latest dividend data.
What sector is Zhejiang Shapuaisi Pharmaceutical Co Ltd in?
Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 603168 listed on?
603168 is listed on SHG.
What is Zhejiang Shapuaisi Pharmaceutical Co Ltd's net margin?
Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) reports a net margin of -13.7% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.